Stock Screener App

Frei -

Installieren

1.23

4.65% -0.06

Ovid Therapeutics Inc (OVID)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Ovid Therapeutics Inc-Aktie (OVID)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	71.05% 0.13	0.076	0.173	0.169	0.148
Operating Expenses	17.43% 12.68	10.80	13.40	20.69	17.57
Benefits Costs and Expenses	11.11% 10.37	9.329	14.18	-8.352	11.84
Costs And Expenses	11.11% 10.37	9.329	14.18	-8.352	11.84
Operating Income/Loss	17.05% -12.55	-10.72	-13.23	-20.52	-17.42
Income/Loss From Continuing Operations Before Tax	10.61% -10.23	-9.253	-14.01	8.521	-11.69
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	10.61% -10.23	-9.253	-14.01	8.521	-11.69
Net Income/Loss	10.61% -10.23	-9.253	-14.01	8.521	-11.69
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	100.00% -	-0.458	-	-	-

INCY

$86.64

1.40%

GMAB

$27.54

0.58%

SMMT

$25.98

9.16%

BNTX

$112.46

8.66%

INSM

$145.10

1.80%

ONC

$341.80

7.24%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters